Firazyr 30 mg/3 ml, Injektionslösung in einer Fertigspritze

7680581780015 CH-58178 Injektionslösung
Firazyr 30 mg/3 ml, Injektionslösung in einer Fertigspritze
Firazyr 30 mg/3 ml, Injektionslösung in einer Fertigspritze
1 / 2
google

Article details

Package size
1 x 3
Selling units
1
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
05/03/2025
Patient information leaflet
Français
05/03/2025
Patient information leaflet
Italien
05/03/2025
Summary of Product Characteristics
Allemand
05/03/2025
Summary of Product Characteristics
Français
05/03/2025
Summary of Product Characteristics
Italien
05/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.35 MG Substance HBESI

Reimbursement information

Public price
CHF 1951.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2010

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
58178
Drug name
Firazyr, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
B06AC02
Authorization status
Z
Dispensing category
B
First authorization
17/06/2009
Authorization expiration date
31/12/9999
IT Number
02.99.0.
Domain
Human medicine
Field of application
Behandlung von Angioödem (Treatment of Angioedema)

Package details

Description (FR)
FIRAZYR sol inj 30 mg/3ml ser pré 3 ml
Description (DE)
FIRAZYR Inj Lös 30 mg/3ml Fertspr 3 ml
Market launch
17/06/2009
Narcotic (BTM)
No

Available generics (2)

Icatibant Spirig HC 30 mg, Injektionslösung in einer Fertigspritze
GTIN: 7680682630011
CHF 806.15
View
Icatibant Spirig HC 30 mg, Injektionslösung in einer Fertigspritze
GTIN: 7680682630028
CHF 806.15
View